Why the study?
Does targeting the sympathetic nervous system improve blood pressure control in patients with obesity-associated hypertension?
Does targeting the sympathetic nervous system improve blood pressure control in patients with obesity-associated hypertension?
This commentary highlights the pathophysiological role of the sympathetic nervous system in obesity-associated hypertension and its potential as a therapeutic target.
A n estimated 60% to 70% of hypertension may be attributed to obesity. Considering that 30% of hypertensive subjects are undiagnosed, 40% remain untreated, and, of those being treated, 65% do not meet treatment goals, 2 the opening of the spigot of obesityassociated hypertension will result in an ever-growing number of patients with uncontrolled hypertension, particularly because obesity is a predictor of poor blood pressure control. t is important, therefore, to understand the pathophysiology of obesity-associated hypertension. This commentary focuses on the role that the sympathetic nervous system plays in this condition and its relevance to treatment.
No takes yet. Share an insight, caveat, or question.
Italo Biaggioni (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: